Pretargeting methods and compounds
AssigneeNeoRx Corporation
InventorsEric K. Yau, Louis J. Theodore, Linda M. Gustavson
Life of this patent
Estimating the term…
Abstract
Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods for radiometal labeling of biotin, as well as related compounds, are described. Articles of manufacture useful in pretargeting methods are also discussed.
Claims10
A method of producing nitro-benzyl-DOTA via the select N-alkylation of a compound having a trifluoroacetamide group with an iodoacetyl derivative in the presence of base comprising:
- treating an acyclic tripeptide having an N-terminal amino group and a C-terminal carboxyl group with an activating agent such that said carboxyl group of said acyclic tripeptide becomes susceptible to closure by said amino group;
- and
- allowing said acyclic tripeptide to cyclize to form a cyclic tripeptide.
A method for the synthesis of 2-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane which comprises:
- (i) reacting ethylenediamine with N-BOC-p-nitrophenylglycinate to produce ##STR49## (ii) reacting the product of (i) with CF.sub.3 CO.sub.3 Et and methanol to produce ##STR50## (iii) reacting the product of (ii) with ##STR51## in the presence of NaH and THF to produce ##STR52## (iv) reacting the product of (iii) with THF and CH.sub.2 Cl.sub.2 to produce ##STR53## (v) reacting the product of (iv) with benzotriazolyl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP), DMF and DIEA to produce ##STR54## (vi) reacting the product of (v) with NH.sub.4 OH and methanol to produce ##STR55## (vii) reacting the product of (vi) with BH.sub.3 and THF to produce 2-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane.
A method of producing the product ##STR56## comprising the following steps:
- treating an acyclic tripeptide having an N-terminal amino group and a C-terminal carboxyl group with an activating agent under conditions wherein the carboxyl group of said acyclic tripeptide becomes susceptible to closure by said amino group, and wherein the acyclic tripeptide is glycyl-N-ethylenediamino-N'-trifiuoroacetyl-N'-methylcarbonyl-p-nitropheny lalanine;
- and wherein cyclization is effected with benzyltriazolyloxy-tris(dimaethylamino)phosphoride hexafiuoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA) to produce a cyclic peptide compound having the following structure:
- ##STR57## reacting the previous cyclic compotmd in the presence of ammonium hydroxide and methanol to produce said product.
A method of producing the following product:
- ##STR58## comprising the following steps:
- treating an acyclic peptide having an N-tenninal amino group and a C-terminal carboxyl group with an activating agent under conditions wherein the carboxyl group of said acyclic peptide becomes susceptible to closure by said amino group, and wherein the acyclic tripeptide is glycyl-N-ethylenediamino-N'-trifluoroacetyl-N'-methylcarbonyl-p-nitropheny lalanine;
- and cyclization is effected with benzotriazolyloxy-tris(dimethylamino)phosphoride hexafluoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA) to produce a cyclic peptide compound having the following structure:
- ##STR59## reacting the previous cyclic coinpound in the presence of ammonium hydroxide and methanol to produce the following compound:
- ##STR60## and reacting the previous compound with BF.sub.3 and THF to produce said product.
Dependencies are inferred from the claim text.